XYLO is a biotechnology firm that offers services for neurological and psychiatric conditions.
Xylo Bio's investors include Gaingels, Main Sequence Ventures, Lionheart Ventures, One Mind Accelerator, Possible Ventures.
Xylo Bio is headquartered in Boulder, United States.
XYLO is a biotechnology firm that offers services for neurological and psychiatric conditions.
Xylo Bio is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Xylo Bio — Funding & Investors." VCBacked, February 21, 2025, https://www.vcbacked.co/company/xylo-bio. Accessed July 19, 2026.
VCBacked. (2025). Xylo Bio — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/xylo-bio
{{cite web |title=Xylo Bio — Funding & Investors |url=https://www.vcbacked.co/company/xylo-bio |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated